Overview

Continuous Oxytocin Infusion Versus Pulsatile Intravenous Oxytocin for Augmentation of First Stage of Labor

Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
0
Participant gender:
Female
Summary
Comparing continuous intravenous oxytocin infusion with pulsatile administration of intravenous oxytocin for augmentation of the first stage of labor.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ain Shams Maternity Hospital
Treatments:
Oxytocin
Criteria
Inclusion Criteria

1. Women in labor (cervical dilatation 3-4 centimeters) who require augmentation of first
stage of labor.

2. Single viable fetus.

3. Rupture of membranes before augmentation of labor.

4. Cephalic presentation.

5. Term pregnancy.

Exclusion Criteria:

1. Malpresentation.

2. Induction of labor by prostaglandins.

3. Any uterine previous surgery.

4. Fetal anomalies.

5. Premature labor.

6. Previous cesarean section.

7. Any uterine anomalies.

8. Multiple pregnancy.